Search
Now showing items 1-2 of 2
Humoral response after a BNT162b2 heterologous third dose of COVID- 19 vaccine following two doses of BBIBP-CorV among healthcare personnel in Peru
(Sociedad Japonesa de Vacunología, 2023-05)
Background: The inactivated virus vaccine, BBIBP-CorV, was principally distributed across low- and
middle-income countries as primary vaccination strategy to prevent poor COVID-19 outcomes. Limited
information is available ...
Post-vaccination seropositivity against SARS-CoV-2 in peruvian health workers vaccinated with BBIBP-CorV (Sinopharm)
(Royal College of Physicians and Surgeons de Glasgow, 2023-04)
Objective: To estimate the prevalence of post-vaccination seropositivity against SARS-CoV-2 and identify its predictors in Peruvian Social Health Insurance (EsSalud) personnel in 2021.
Methods: We conducted a cross-sectional ...